145 related articles for article (PubMed ID: 6333873)
1. The role of binding ligand in toxic hybrid proteins: a comparison of EGF-ricin, EGF-ricin A-chain, and ricin.
Herschman HR
Biochem Biophys Res Commun; 1984 Oct; 124(2):551-7. PubMed ID: 6333873
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-toxin A chain conjugates: EGF-ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxic.
Cawley DB; Herschman HR; Gilliland DG; Collier RJ
Cell; 1980 Nov; 22(2 Pt 2):563-70. PubMed ID: 6256086
[TBL] [Abstract][Full Text] [Related]
3. Toxic ligand conjugates as tools in the study of receptor-ligand interactions.
Herschman HR; Simpson DL; Cawley DB
J Cell Biochem; 1982; 20(2):163-76. PubMed ID: 6188758
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.
Vollmar AM; Banker DE; Mendelsohn J; Herschman HR
J Cell Physiol; 1987 Jun; 131(3):418-25. PubMed ID: 3496342
[TBL] [Abstract][Full Text] [Related]
5. Killing of cultured hepatocytes by conjugates of asialofetuin and EGF linked to the A chains of ricin or diphtheria toxin.
Simpson DL; Cawley DB; Herschman HR
Cell; 1982 Jun; 29(2):469-73. PubMed ID: 6180832
[TBL] [Abstract][Full Text] [Related]
6. HeLa cell mutants resistant to epidermal growth factor ricin A-chain conjugate.
Banker D; Herschman HR
J Cell Physiol; 1989 Apr; 139(1):42-50. PubMed ID: 2785116
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of ricin and diphtheria toxin-antibody-conjugate kinetics on protein synthesis inactivation.
Esworthy RS; Neville DM
J Biol Chem; 1984 Sep; 259(18):11496-504. PubMed ID: 6470010
[TBL] [Abstract][Full Text] [Related]
8. An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypes.
Banker DE; Pastan I; Gottesman MM; Herschman HR
J Cell Physiol; 1989 Apr; 139(1):51-7. PubMed ID: 2496133
[TBL] [Abstract][Full Text] [Related]
9. EGF-ricin A conjugates: kinetic profiles of cytotoxic effects and resistant cell variants.
Shimizu N; Shimizu Y; Miskimins WK
Cell Struct Funct; 1984 Sep; 9(3):203-12. PubMed ID: 6096027
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
11. Antibody-ricin conjugates: a method of linkage which blocks the galactose binding site of ricin.
Foxwell BM; Ross WC; Thorpe PE
Behring Inst Mitt; 1984 May; (74):101-7. PubMed ID: 6477350
[TBL] [Abstract][Full Text] [Related]
12. A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation.
Sokołowska I; Wälchli S; Węgrzyn G; Sandvig K; Słomińska-Wojewódzka M
Biochem J; 2011 Jun; 436(2):371-85. PubMed ID: 21388347
[TBL] [Abstract][Full Text] [Related]
13. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
14. The binding of ricin to its receptor is not required for the expression of its toxicity.
Morino H; Sakakibara R; Ishiguro M
Biol Pharm Bull; 1995 Dec; 18(12):1770-2. PubMed ID: 8787805
[TBL] [Abstract][Full Text] [Related]
15. Recombinant hybrid toxin with dual enzymatic activities. Potential use in preparing highly effective immunotoxins.
Li BY; Ramakrishnan S
J Biol Chem; 1994 Jan; 269(4):2652-8. PubMed ID: 8300596
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence.
O'Hare M; Brown AN; Hussain K; Gebhardt A; Watson G; Roberts LM; Vitetta ES; Thorpe PE; Lord JM
FEBS Lett; 1990 Oct; 273(1-2):200-4. PubMed ID: 2121540
[TBL] [Abstract][Full Text] [Related]
17. Variant of A431 cells isolated by ricin A-conjugated monoclonal antibody directed to EGF receptor: phosphorylation of EGF receptor and phosphatidylinositol.
Behzadian MA; Shimizu N
Somat Cell Mol Genet; 1985 Nov; 11(6):579-91. PubMed ID: 3000001
[TBL] [Abstract][Full Text] [Related]
18. A Simple Fluorescence-based Reporter Assay to Identify Cellular Components Required for Ricin Toxin A Chain (RTA) Trafficking in Yeast.
Becker B; Schmitt MJ
J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286473
[TBL] [Abstract][Full Text] [Related]
19. The role of ricin B chain in the intracellular trafficking of anti-CD5 immunotoxins.
Manske JM; Buchsbaum DJ; Vallera DA
J Immunol; 1989 Mar; 142(5):1755-66. PubMed ID: 2465347
[TBL] [Abstract][Full Text] [Related]
20. Insulin-ricin B hybrid molecules: receptor binding and biological activity in a minimal-deviation hepatoma cell line.
Hofmann CA; Lotan RM; Rath GD; Oeltmann TN
Arch Biochem Biophys; 1983 Dec; 227(2):448-56. PubMed ID: 6364983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
